Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Evaluation of Vitreous Modifications After Cataract Surgery (VitCat)

11. september 2026 oppdatert av: Marco Rocco Pastore, University of Trieste

Assessment of Vitreous Changes Following Cataract Surgery

This study aims to evaluate changes in vitreous structure and the vitreoretinal interface following cataract surgery using spectral-domain optical coherence tomography (OCT). Patients undergoing cataract surgery will undergo standardized OCT imaging before and after surgery. Preoperative and postoperative images will be compared to identify and characterize qualitative and quantitative changes in vitreous morphology, with particular attention to the posterior vitreous and its relationship with the retinal surface.

Studieoversikt

Detaljert beskrivelse

Cataract surgery may induce anatomical and biomechanical changes within the vitreous body and at the vitreoretinal interface. However, the extent and characteristics of these modifications remain incompletely defined, particularly when assessed using high-resolution optical coherence tomography (OCT).

The aim of this study is to investigate structural changes in the vitreous and vitreoretinal interface occurring after cataract surgery through a standardized preoperative and postoperative spectral-domain OCT imaging protocol.

Patients with cataract scheduled for surgery will be considered for inclusion. Eligible participants must have OCT images of sufficient quality for reliable assessment and no evidence of posterior vitreous detachment (PVD) at baseline. Both preoperative and postoperative OCT imaging must be available for comparative analysis.

Standardized OCT acquisition will include the 18 Line R64 and AS Star 18 Line R16 imaging protocols using the Dream OCT platform. These scans will be used to assess the posterior vitreous, its relationship with the retinal surface, and any postoperative changes in vitreous morphology or vitreoretinal interface configuration.

Preoperative and postoperative images will be compared both qualitatively and quantitatively. The analysis will focus on identifying changes in the visibility, configuration, position, and attachment of the posterior vitreous structures, as well as any modifications of the vitreoretinal interface occurring following cataract surgery.

Patients will be excluded in the presence of factors that may interfere with accurate vitreous assessment or independently alter vitreoretinal anatomy. These include advanced cataract significantly compromising OCT image quality, pre-existing posterior vitreous detachment, previous vitreous hemorrhage, previous vitreoretinal surgery, prior intravitreal injections, retinal diseases affecting evaluation of the vitreoretinal interface, pathologic high myopia, and a history of ocular trauma or uveitis.

The primary objective is to quantitatively and qualitatively characterize postoperative changes in vitreous morphology and vitreoretinal interface features after cataract surgery. The study is intended to improve understanding of the early structural effects of cataract surgery on the vitreous and to determine whether OCT imaging can reliably document these postoperative modifications.

Studietype

Observasjonsmessig

Registrering (Antatt)

15

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Paris
      • Créteil, Paris, Frankrike, 94000
        • Rekruttering
        • Centre Hospitalier Intercommunal de Créteil
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Patients scheduled for cataract surgery without posterior vitreous detachment

Beskrivelse

Inclusion Criteria:

  • Presence of cataract scheduled for surgery
  • Adequate image acquisition quality
  • Absence of posterior vitreous detachment (PVD)
  • Availability of both preoperative and postoperative OCT imaging

Exclusion Criteria:

  • Advanced cataract significantly compromising image quality
  • Presence of posterior vitreous detachment (PVD)

    • History of vitreous hemorrhage
    • Previous vitreoretinal surgery
    • Previous intravitreal injections (IVT)
    • Retinal diseases affecting vitreoretinal interface assessment
    • Pathologic high myopia
    • History of ocular trauma or uveitis

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
No vitreous detachment
Patients scheduled for cataract surgery without posterior vitreous detachment
standard cataracte surgery

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Number of Participants With Postoperative Changes in Vitreous Morphology or Vitreoretinal Interface Configuration
Tidsramme: 4 weeks
Preoperative and postoperative OCT images will be compared to identify participants showing structural changes in the posterior vitreous or vitreoretinal interface, including changes in posterior hyaloid position, vitreoretinal attachment status, and the development of partial or complete posterior vitreous detachment (PVD). Results will be reported as the number and proportion of participants presenting these postoperative changes.
4 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. juli 2026

Primær fullføring (Antatt)

20. september 2026

Studiet fullført (Antatt)

20. oktober 2026

Datoer for studieregistrering

Først innsendt

3. september 2026

Først innsendt som oppfylte QC-kriteriene

11. september 2026

Først lagt ut (Faktiske)

14. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

14. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

11. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

Individual participant data are not planned to be publicly shared. However, fully anonymized data may be considered for sharing with qualified researchers upon reasonable request, subject to applicable ethical, institutional, and data protection requirements.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere